StonvexLoading…
StonvexCore line items from TRVG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | €548.91M | €460.85M | €485.03M | €535.00M |
Operating Income | €1.53M | €-32.15M | €-156.59M | €-120.26M |
Net Income | €11.22M | €-23.70M | €-164.48M | €-127.22M |
EPS (Diluted) | €0.03 | €-0.07 | €-0.48 | €-0.36 |
Total Assets | €358.45M | €300.72M | €325.07M | €691.59M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | €131.07M | €134.09M | €102.19M | €248.93M |
Free Cash Flow OCF − CapEx | €3.22M | €17.45M | €24.29M | €62.29M |
Shares Outstanding | 357.59M | 349.62M | 344.94M | 357.55M |